Related Experiment Video
Updated: Aug 11, 2026
08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
[Hyperglycemia in toxic oil syndrome]
A Sáenz Calvo1, M García del Valle, E Cordón Rodríguez
1Centro de Salud Gómez Acebo. Insalud Area/Sector 11 de Madrid.
Atencion Primaria
|May 31, 1995
Summary
Patients with Spanish toxic oil syndrome (TOS) exhibit significantly higher rates of hyperglycemia compared to controls. This study highlights a critical link between TOS and glucose metabolism disturbances.
Area of Science:
- Endocrinology
- Toxicology
- Epidemiology
Background:
- The Spanish toxic oil syndrome (TOS) is a unique mass poisoning incident with long-term health consequences.
- Hyperglycemia and its associated metabolic disturbances are potential sequelae of environmental exposures.
Purpose of the Study:
- To determine the prevalence of hyperglycemia in patients with TOS.
- To identify clinical, biochemical, and pathological factors associated with hyperglycemia in TOS.
- To compare hyperglycemia prevalence in TOS patients with a control group.
Main Methods:
- A case-control study was conducted.
- Participants included 734 patients with TOS and 1474 control subjects.
- Data were collected from Primary Health Care in Madrid's XI Sanitary district.
Main Results:
- The prevalence of hyperglycemia (including impaired glucose tolerance and diabetes mellitus) was 13% in TOS patients versus 3.8% in controls (p < 0.001).
- TOS patients showed significantly higher rates of impaired glucose tolerance (2.95% vs 0.07%), non-insulin-treated diabetes (7.78% vs 3.26%), and insulin-treated diabetes (1.99% vs 0.47%).
- Pancreatic lesions in deceased TOS patients included vasculitis and endothelial vascular lesions, differing from typical diabetes mellitus pathology.
Conclusions:
- Hyperglycemia is significantly more prevalent in individuals with TOS.
- The observed pancreatic lesions in TOS patients suggest a distinct pathological mechanism not commonly associated with diabetes mellitus.
- Further research is warranted to understand the long-term metabolic impact of TOS.
Related Concept Videos
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:21Hyperosmolar Hyperglycemic State
Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...
01:22Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...